Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity

Hypertension

Volumn 27, Issue 1, 1996, Pages 62-66

  Bloem, Laura J ^b   Manatunga, Amita K ^b   Pratt, J Howard ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

angiotensin converting enzyme; blacks; blood pressure; genes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 0030070807     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.1.62     Document Type: Article

References (46)

1. Soubrier F, Hubert C, Testut P, Nadaud S, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme, I: biochemistry and structure of the gene. J Hypertens. 1993;11:471-476.
2. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
3. Dux S, Aron N, Boner G, Carmel A, Yaron A, Rosenfeld JB. Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension, Ir J Med Sci. 1984;20:1138-1142.
4. Alhenc-Gelas F, Richard J, Corbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991;117:33-39.
5. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakolovao R, Gonzales MF, Allegrini J, Bloch C. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet. 1988;43:774-780.
6. Rigat B, Hubert C, Corvol P, Souhrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
8. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F, Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma levels. Am J Hum Genet. 1992;51:197-205.
9. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiolensin-eonverting enzyme is a potent risk factor for myocardial infarction. Naature. 1992;359:641-644.
10. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. QJM. 1994;87:211-214.
11. Tiret L, Kee F, Poirier O, Niehols NR, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in angiotensin-converling enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
12. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Camhou JP, Rakotovao R, Ducimeliere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiolensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
13. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates wild coronary arlery disease in the Caerphilly Heart Study. Circulation. 1995;91:270-274.
14. Bohn M, Berge K, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 1993;44:292-297.
15. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis. 1995;112:137-143.
16. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
17. Sehunkert H, Honse H, Holmer S, Stender M, Perz S, Keil U, Lorell B, Riegger G. Association between a deletion polymorphism of the angiotensin-converting-cnzyme nene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
18. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
19. Zee RYL, Lou Y, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992;184:9-15.
20. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun. 1993;191:399-404.
21. Morise T, Takeuchi Y, Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet. 1994;343:125.
22. Harrap SB, Oavidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM. The angiotensin 1 converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
23. Cavalli-Sforza LL, Menozzi P, Piazza A. Demie expansions and human evolution. Science. 1993;259:639-646.
24. Brunner HR, Laragh JH, Baer L. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972;286:441-449.
25. Kaplan NM, Kem DC, Holland OB, Kramer NJ, Higgins J, Gomez-Sanchez C. The intravenous furosemide test: a simple way to evaluate renin responsiveness. Ann Intern Med. 1976;84:639-645.
26. Kotchen TA. Guthrie GP Jr, Cottrill CM, McKean HE, Kotchen JM. Low renin-aldosterone in 'prehypertensive' young adults. J Clin Endocrinol Metab. 1982;54:808-814.
27. Manatunga AK, Jones JJ, Pratt JH. Longitudinal assessment of blood pressures in black and white children. Hypertension. 1993;22:84-89.
28. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986;78:31-39.
29. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365-372.
30. Liung KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
31. Alhenc-Gelas F, Weare JA, Johnson RL Jr, Erdos EG. Measurement of human converting enzyme level by direct radioimmunoassay. J Lab Clin Med. 1983;101:83-96.
32. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engt J Med. 1989;321:1152-1157.
33. Pratt JH, Manatunga AK, Bloem LJ, Wei L. Racial differences in aldosterone excretion: a longitudinal study in children. J Clin Endocrinol Metab. 1993;77:1512-1515.
34. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens. 1994;12:955-957.
35. Rodriguez GE, Shin BC, Abernathy RS, Kendig EL Jr. Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. J Pediatr. 1994;99:68-72.
36. Reed TE. Caucasian genes in American Negroes. Science. 1969; 165;762-768.
37. Chakraborty R, Kamboh MI, Nwankwo M, Ferrell RE. Caucasian genes in American blacks: new data. Am J Hum Genet. 1992;50:145-155.
38. Wei L, Alhenc-Gelas F, Soubrier F, Midland A, Corvol P, Clauser E. Expression and characterization of recombinanl human angiotensin I-converting enzyme. J Biol Chem. 1991;266:5540-5546.
39. Hooper NM. Angiotensin converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem. 1991;23:641-647.
40. Kimbrough HM, Vaughan ED, Carey RM, Ayers CR. Effect of intrarenal angiotcnsin II blockade on renal function in conscious dogs, Circ Res. 1977;40:174-177.
41. Schachter F, Faure-Delanef I., Ouenul F, Ronger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
42. Sartwell PE. Racial differences in sarcoidosis. Ann N Y Acad Sci. 1976;278:368-370.
43. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, DeGouyon B, Julier C, Takahasi S, Vincent M, Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521-529.
44. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao Y-P, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67:213-224.
45. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel J-M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
46. Niarchos AP, Resnick LM, Weinstein DL, Laragh JH. Angiotensin I converting enzyme activity in hypertension. Am J Med. 1985;79:435-444.